Search

everythinglearnresearchcommunity

for

Search:↓

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

Autoimmune skin disorders are caused by genetic and environmental factors and are treated with various medications and preventative strategies.

SLE can cause unusual gastrointestinal symptoms, and immunosuppressive therapy can be effective.

Thyroid disorders, especially autoimmune ones, are very common in the studied group.

Different rheumatological diseases can cause specific skin problems.

New technologies show potential for better understanding and treating skin conditions with abnormal mucin, but more research is needed for clinical use.

Certain skin symptoms can indicate underlying body-wide illnesses.

Folliculotropic mycosis fungoides can look like alopecia areata.

A patient with patchy hair loss was successfully treated for Tumid Lupus Erythematosus after other treatments failed.

A woman with both TLE and SLE improved with hydroxychloroquine treatment.

Alopecia can be linked to autoimmune issues, vitiligo, nail problems, and sometimes cancer treatments.

Consider infectious diseases like visceral leishmaniasis before diagnosing autoimmune hepatitis.

A dog's skin and digestive problems improved after treatment for thyroid cancer.

A specific type of immune cell plays a key role in causing alopecia areata and could be a target for treatment.

Special immune cells called Regulatory T cells help control skin inflammation and repair in various skin diseases.

Down Syndrome patients with Alopecia Areata often have hypothyroidism and specific immune abnormalities.

Patients with GATA2 deficiency show early skin symptoms that help diagnose the condition.

Colectomy led to hair regrowth in a Crohn's patient with alopecia areata.

Epigenetic changes contribute to autoimmune skin diseases.

Early diagnosis, intensive therapy, and careful follow-up are crucial for managing overlapping TTP and SLE.

Cutaneous Lymphadenoma is a unique skin tumor with specific protein markers and common gene mutations that may cause continuous cell growth.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

Ustekinumab treatment may reveal a genetic tendency for steatocystoma multiplex in psoriasis patients.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

Frontal fibrosing alopecia might be linked to autoimmune diseases.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

A 16-year-old boy had pernicious anemia, autoimmune hemolytic anemia, and later developed alopecia areata.

Hidradenitis suppurativa may be more severe in people with Mediterranean fever gene mutations.